Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry

Jean Francois H Geschwind,Pierre M. Gholam,Alec Goldenberg,Parvez S. Mantry,Robert C. G. Martin,Bilal Piperdi,Ellen Zigmont,Joanne Imperial,Svetlana Babajanyan,Pamela K. Foreman,Allen Lee Cohn

Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry

2016

Jean Francois H Geschwind
Pierre M. Gholam
Alec Goldenberg
Parvez S. Mantry
Robert C. G. Martin
Bilal Piperdi
Ellen Zigmont
Joanne Imperial
Svetlana Babajanyan
Pamela K. Foreman
Allen Lee Cohn

Background: Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Treatment with Sorafenib (GIDEON) is a worldwide, prospective, non-in

Keywords:

Hepatocellular carcinoma
Cancer research
Sorafenib
Pathology
Medicine
Oncology
Internal medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations